There is a glaring gap in diagnosing and monitoring patients for brain edema and bleeding. At most, CT (computed tomography) and MRI (magnetic resonance imaging) only provide daily snapshots, and other probes like intracranial pressure (ICP) monitors are extremely invasive and are only used in the most serious cases. Most patients are left largely unmonitored in their hospital beds, except for periodic subjective clinical neurological exams, leaving them exposed to a risk of undetected brain edema or bleeding, until it causes a significant and detectable neurological deficit—and by then it is too late. Cerebrotech will offer a completely noninvasive device for monitoring small changes in brain edema and bleeding, which will provide a continuous and objective measure of brain fluids and ischemia at the patient's bedside. Patients include over 3 million admitted each year worldwide for stroke, traumatic brain injury, brain surgery, and other disorders that place them at high risk for clinical degradation. Early detection of adverse changes in patient condition is the key to improving outcomes and reducing cost for hospitals and payers.